en

PRODUCT DETAIL

Kisqali 200 mg filmom obalené tablety

Code 5085C
MA number EU/1/17/1221/003
Product Form: tbl flm 42x200 mg (blis.PCTFE/PVC)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EF Cyclin-dependent kinases (CDK) inhibitors
L01EF02 Ribociclib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.08.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 25.07.2022
eu-flag.png sk-flag.png